New Key Statistics Module, Z-Score and F-Score
NAS:TGTX Key Ratios
| Market Cap $ M | 5,063.79 |
| Enterprise Value $ M | 4,976.56 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 33.74 |
| Price/Book | 26.36 |
| Price/Sales | 19.15 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 264.00 |
| EPS (TTM) $ | -0.11 |
| Beneish M-Score | -0.97 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 881.90 |
| EV-to-EBITDA | 836.12 |
| PEG | -- |
| Shares Outstanding M | 155.67 |
| Net Margin (%) | -5.43 |
| Operating Margin % | -0.19 |
| Pre-tax Margin (%) | -5.24 |
| Quick Ratio | 3.91 |
| Current Ratio | 4.59 |
| ROA % (ttm) | -3.55 |
| ROE % (ttm) | -8.40 |
| ROIC % (ttm) | -0.59 |
| Dividend Yield % | -- |
| Altman Z-Score | 5.41 |
TGTX Number of Guru Trades
TGTX Volume of Guru Trades
Gurus Latest Trades with NAS:TGTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TGTX is held by these investors
Total 1
TG Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TGTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers